![Samit Govindji Hathi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Samit Govindji Hathi
Gründer bei Gowrie Laxmico Ltd.
Aktive Positionen von Samit Govindji Hathi
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Gowrie Laxmico Ltd.
![]() Gowrie Laxmico Ltd. Medical DistributorsDistribution Services Gowrie Laxmico Ltd. distributes pharmaceutical products. The company was founded on October 8, 1997 and is headquartered in Middlesex, the United Kingdom. | Direktor/Vorstandsmitglied | 01.01.1999 | - |
Vorstandsvorsitzender | 01.01.1999 | - | |
Gründer | 01.01.1999 | - | |
Laxmi BNS Holdings Ltd.
![]() Laxmi BNS Holdings Ltd. Drugstore ChainsRetail Trade Founded in 2010, Laxmi BNS Holdings Ltd. is a pharmaceutical distribution and British sales company. The company is based in Ruislip, UK. | Direktor/Vorstandsmitglied | 10.02.2010 | - |
Laxmico Ltd.
![]() Laxmico Ltd. Medical DistributorsDistribution Services Part of Gowrie Laxmico Ltd., Laxmico is a wholesaler of pharmaceutical products. The company is based in Ruislip, UK. Laxmico was founded in 2009. | Direktor/Vorstandsmitglied | - | - |
Novalgen Ltd.
![]() Novalgen Ltd. BiotechnologyHealth Technology Part of Convergys Capital Ltd., Novalgen Ltd. is a clinical stage immunology company based in Northwood Hills, UK. Novalgen is developing breakthrough immunotherapies for people with immunologically driven diseases using their autoregulation platform. The British company's lead program, NVG-111, is an ROR1-targeting bispecific antibody T-cell engager for the treatment of both hematological malignancies and solid tumors using their breakthrough bispecific antibody technology. The company's lead AR program, NVG-222, builds on the success of NVG-111 and is primed for entry into the clinic in 2024. The company was founded by Amit Chunilal Nathwani and has been the CEO since incorporation. | Direktor/Vorstandsmitglied | - | - |
Syri Ltd. (United Kingdom)
![]() Syri Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Part of Gowrie Holdings Ltd., Syri Ltd. is a British UK-based company founded in 2010. The company specializes in the development, licensing, manufacture, and marketing of liquid medicines. | Direktor/Vorstandsmitglied | 02.12.2010 | - |
Karriereverlauf von Samit Govindji Hathi
Statistik
International
Vereinigtes Königreich | 6 |
Operativ
Director/Board Member | 5 |
Chief Executive Officer | 1 |
Founder | 1 |
Sektoral
Distribution Services | 3 |
Health Technology | 3 |
Retail Trade | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Gowrie Laxmico Ltd.
![]() Gowrie Laxmico Ltd. Medical DistributorsDistribution Services Gowrie Laxmico Ltd. distributes pharmaceutical products. The company was founded on October 8, 1997 and is headquartered in Middlesex, the United Kingdom. | Distribution Services |
Laxmi BNS Holdings Ltd.
![]() Laxmi BNS Holdings Ltd. Drugstore ChainsRetail Trade Founded in 2010, Laxmi BNS Holdings Ltd. is a pharmaceutical distribution and British sales company. The company is based in Ruislip, UK. | Retail Trade |
Laxmico Ltd.
![]() Laxmico Ltd. Medical DistributorsDistribution Services Part of Gowrie Laxmico Ltd., Laxmico is a wholesaler of pharmaceutical products. The company is based in Ruislip, UK. Laxmico was founded in 2009. | Distribution Services |
Novalgen Ltd.
![]() Novalgen Ltd. BiotechnologyHealth Technology Part of Convergys Capital Ltd., Novalgen Ltd. is a clinical stage immunology company based in Northwood Hills, UK. Novalgen is developing breakthrough immunotherapies for people with immunologically driven diseases using their autoregulation platform. The British company's lead program, NVG-111, is an ROR1-targeting bispecific antibody T-cell engager for the treatment of both hematological malignancies and solid tumors using their breakthrough bispecific antibody technology. The company's lead AR program, NVG-222, builds on the success of NVG-111 and is primed for entry into the clinic in 2024. The company was founded by Amit Chunilal Nathwani and has been the CEO since incorporation. | Health Technology |
Syri Ltd. (United Kingdom)
![]() Syri Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Part of Gowrie Holdings Ltd., Syri Ltd. is a British UK-based company founded in 2010. The company specializes in the development, licensing, manufacture, and marketing of liquid medicines. | Health Technology |
- Börse
- Insiders
- Samit Govindji Hathi
- Erfahrung